4D Molecular Therapeutics's total assets for Q3 2025 were $423.98M, a decrease of -10.48% from the previous quarter. FDMT total liabilities were $55.00M for the fiscal quarter, a 4.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.